12 studies found for:    "trisomy 18"
Show Display Options
RSS Create an RSS feed from your search for:
"trisomy 18"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Conditions: Down Syndrome (Trisomy 21);   Edwards Syndrome (Trisomy 18);   Patau Syndrome (Trisomy 13);   Turner Syndrome
Intervention:
2 Unknown  Non-Invasive Determination of Fetal Chromosome Abnormalities
Conditions: Down Syndrome (Trisomy 21);   Edward's Syndrome (Trisomy 18);   Patau Syndrome (Trisomy 13);   Klinefelter Syndrome (47, XXY);   and Other Chromosome;   Abnormalities.
Intervention:
3 Recruiting Development of Non-invasive Prenatal Test for Microdeletion/Duplication and Other Genetic Syndromes Based on Fetal DNA Isolated From Maternal Blood
Conditions: Microdeletion Syndromes;   Trisomy 21;   Trisomy 18;   Trisomy 13;   Sex Chromosome Abnormalities
Intervention:
4 Recruiting Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Conditions: Trisomy 13;   Trisomy 18;   Trisomy 21;   Aneuploidy
Intervention: Procedure: Blood Draw
5 Recruiting Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood
Conditions: Trisomy 21;   Trisomy 18;   Trisomy 13;   Sex Chromosome Abnormalities;   Microdeletion Syndromes
Intervention:
6 Recruiting Study of the Efficacy of New Non-invasive Prenatal Tests for Screening for Fetal Trisomies Using Maternal Blood
Conditions: Trisomy 21;   Trisomy 18;   Trisomy 13
Interventions: Other: Integrated prenatal screening for Down's syndrome;   Other: Serum QUAD Assay for aneuploidy screening;   Other: Targeted NIPT assay using ccfDNA in maternal blood;   Other: Un-targeted NIPT assay using ccfDNA in maternal blood;   Other: Harmony™ Test (Ariosa Diagnostics)
7 Recruiting Non-Invasive Chromosomal Evaluation of Trisomy Study
Conditions: Fetal Aneuploidy;   Trisomy 21;   Trisomy 18;   Trisomy 13;   Down Syndrome
Intervention:
8 Recruiting Prenatal Screening for Down Syndrome With DNAFirst
Conditions: Trisomy 21;   Trisomy 18;   Trisomy 13;   Monosomy X
Intervention:
9 Completed Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Conditions: Pregnancy;   Aneuploidy;   Down Syndrome;   Edwards Syndrome
Intervention:
10 Completed Comparison of Aneuploidy Risk Evaluations
Conditions: Pregnancy;   Down Syndrome;   Edwards Syndrome;   Patau Syndrome;   Turners Syndrome
Intervention:
11 Completed Non-Invasive Screening for Fetal Aneuploidy
Conditions: Down Syndrome;   Edwards Syndrome
Intervention: Other: Maternal blood screening test for fetal aneuploidy
12 Completed Non-invasive Prenatal Diagnostic Validation Study
Conditions: Chromosome 13 Aneuploidy;   Chromosome 18 Aneuploidy;   Chromosome 21 Aneuploidy;   Sex Chromosome Aberrations;   Other Microdeletions
Interventions: Procedure: Blood draw;   Procedure: Cheek swab/Saliva Sampling

Indicates status has not been verified in more than two years